Advertisement
Cardiovascular
Subscribe to Cardiovascular
View Sample

FREE Email Newsletter

LX4211 for Diabetes Shown to Reduce Fasting and Post-Prandial Blood Sugar in Healthy Subjects

September 13, 2011 4:33 am | by Bio-Medicine.Org | News | Comments

THE WOODLANDS, Texas, Sept. 13, 2011 /- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX ), a biopharmaceutical company focused on discovering breakthrough treatments for human disease, reported positive data from a recently completed clinical trial and mechanistic study of LX4211, a dual...

External Defibrillator Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017

September 13, 2011 1:33 am | by Bio-Medicine.Org | News | Comments

NEW YORK, Sept. 13, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: External Defibrillator Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 ...

Spaulding Clinical Announces New Strategic Partnership With Frontage Laboratories, Inc.

September 12, 2011 8:34 am | by Bio-Medicine.Org | News | Comments

WEST BEND, Wis., Sept. 12, 2011 /- Frontage Laboratories, Inc., a global full-service Clinical Research Organization with facilities in the US and China, and Spaulding Clinical Research, LLC, a US-based, leading-edge Clinical Pharmacology Unit, ECG Core Lab, and Medical Device...

Advertisement

Out of the Darkness

September 12, 2011 8:34 am | by Bio-Medicine.Org | News | Comments

SAN DIEGO, September 12, 2011 /- - Digital issue looks inside the minds, lives & hearts of responders to 9-11-01 The Journal of Emergency Medical Services ( JEMS ) today announces the publication of a special 150-page four-volume digital issue featuring first-person accounts...

First Client Installation of CyttaConnectâ„¢ Medical Monitoring System

September 12, 2011 8:34 am | by Bio-Medicine.Org | News | Comments

LOS ANGELES, Sept. 12, 2011 /- Cytta Corp (OTCQB: CYCA) is pleased to announce that we have now successfully completed the first client installation and deployment of our remote medical monitoring system.  This installation enables the Company to commence a full scale roll out of its...

Analyses Find Type 2 Diabetes Patients Treated with BYDUREONâ„¢ Experienced Reduction in Cardiovascular Risk Factors: Results Presented at EASD 2011

September 12, 2011 3:33 am | by Bio-Medicine.Org | News | Comments

LISBON, Portugal, Sept. 12, 2011 /- Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN ), Eli Lilly and Company (NYSE: LLY ) and Alkermes, Inc. (Nasdaq: ALKS ) today announced new analyses from the DURATION-3 and -4 trials demonstrating patients treated with the investigational medication...

New Data on EMA401 in Model of Diabetic Neuropathy Presented at 21st Annual NEURODIAB Meeting

September 12, 2011 2:33 am | by Bio-Medicine.Org | News | Comments

MELBOURNE, Australia, September 12, 2011 /-   EMA401 Shown to Improve Nerve and Neurovascular Function Spinifex Pharmaceuticals, an Australian pain drug development company, today announces the presentation of new data from a study of EMA401 in a model of diabetic neuropathy....

Cardica's Cardiac Anastomosis Device Featured in Clinical Presentation on Robotic Cardiac Bypass Procedures

September 9, 2011 8:34 am | by Bio-Medicine.Org | News | Comments

REDWOOD CITY, Calif., Sept. 9, 2011 /- Cardica, Inc. (Nasdaq: CRDC ) today reported that its C-Port® Flex-A® Anastomosis System will be featured in a clinical presentation to cardiothoracic surgeons this afternoon at the East Carolina Heart Institute-International Society for...

Advertisement

Abaxis, Inc. to Present at CL King's 9th Annual Best Ideas Conference 2011

September 9, 2011 8:33 am | by Bio-Medicine.Org | News | Comments

UNION CITY, Calif., Sept. 9, 2011 /- Abaxis, Inc. (NasdaqGS: ABAX), a medical products company manufacturing point-of-care blood analysis systems, announced today that Clint Severson, chairman and chief executive officer, will present at CL King's 9th Annual Best Ideas Conference 2011 on...

Rottenstein Law Group Produces Videos to Inform Public About Paxil History, Dangers, and Litigation

September 9, 2011 3:33 am | by Bio-Medicine.Org | News | Comments

NEW YORK, Sept. 9, 2011 /- The Rottenstein Law Group, which represents clients with claims stemming from the severe side effects of the antidepressant Paxil, has produced a series of brief videos specifically intended to educate the public about the history of Paxil, possible dangers to...

Anthera Pharmaceuticals Announces Notice of Allowance of U.S. Patent Application Covering A-002 Plus Statin Compositions

September 8, 2011 6:34 pm | by Bio-Medicine.Org | News | Comments

HAYWARD, Calif., Sept. 8, 2011 /- Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH ), a biopharmaceutical company developing drugs to treat serious diseases associated with inflammation, today announced that the U.S. Patent and Trademark Office has given the Company a Notice of Allowance for...

Rescheduled Webcast: Isis Pharmaceuticals Hosts Dr. John Kastelein to Review Mipomersen Long-term Data Recently Presented at ESC Congress 2011

September 8, 2011 6:33 pm | by Bio-Medicine.Org | News | Comments

CARLSBAD, Calif., Sept. 8, 2011 /- Isis Pharmaceuticals, Inc. (Nasdaq: ISIS ) announces the following webcast:What: Data from Mipomersen's Open-Label Extension Study presented at ESCWhen: Monday, September 12, 2011 at 12:00 p.m. ET / 9:00 a.m. PTWhere: www.isispharm.comHow: Live...

Nile Therapeutics to Present at Rodman & Renshaw Global Investment Conference

September 8, 2011 9:34 am | by Bio-Medicine.Org | News | Comments

SAN MATEO, Calif., Sept. 8, 2011 /- Nile Therapeutics, Inc. (OTCQB: NLTX), a company focused on the development of novel therapeutics for cardiovascular disease, today announced that Daron Evans, Chief Financial Officer, will present at the Rodman & Renshaw 13th Annual Global...

Advertisement

Abaxis to Present at 2011 Morgan Stanley Global Healthcare Unplugged Conference

September 8, 2011 6:33 am | by Bio-Medicine.Org | News | Comments

UNION CITY, Calif., Sept. 8, 2011 /- Abaxis, Inc. (NasdaqGS: ABAX), a medical products company manufacturing point-of-care blood analysis systems, announced today that Clint Serverson, chief executive officer,  will present at 2011 Morgan Stanley Global Healthcare Unplugged...

MarketsandMarkets: Year 2008 Recorded Highest Number of Clinical Trials (10,326) during the Study Period (2007-2010)

September 8, 2011 6:33 am | by Bio-Medicine.Org | News | Comments

DALLAS, September 8, 2011 /- The report " Global Clinical Trials Market (2007 - 2010) " analyses the total number of clinical trials conducted globally from 2007 to 2010 by phases, study design, indications, and major market drivers, restraints, and opportunities for the clinical...

Regulus Therapeutics to Present New Advancements in microRNA Therapeutics for Treatment of Metabolic Diseases and Cancer

September 8, 2011 6:33 am | by Bio-Medicine.Org | News | Comments

LA JOLLA, Calif., Sept. 8, 2011 /- Regulus Therapeutics Inc ., a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, today announced the presentation of recent advances in its microRNA therapeutic preclinical programs for the...

Angioslide Announces the European Launch of New 300 mm Long Device Allowing Treatment of Entire Superficial Femoral Artery(SFA) with One Device

September 8, 2011 6:33 am | by Bio-Medicine.Org | News | Comments

CAESAREA, Israel, September 8, 2011 /- Angioslide Ltd. announces the first procedures with its new 5x300mm PROTEUS device for treating the Superficial Femoral Artery (SFA ) .  PROTEUS technology combines a Percutaneous Transluminal Angioplasty (PTA) balloon and embolic capture of...

Concentric Medical Completes Enrollment in Prospective Multi Center Stentrieverâ„¢ Trial for Mechanical Thrombectomy in Stroke

September 8, 2011 3:33 am | by Bio-Medicine.Org | News | Comments

MOUNTAIN VIEW, Calif., Sept. 8, 2011 /- Concentric Medical, Inc., a global leader in acute ischemic stroke intervention, today announced completion of enrollment of the TREVO Study.  The TREVO Study ( T hrombectomy RE vascularization of large V essel O cclusions in acute...

Global Intravascular Ultrasound (IVUS) Industry

September 8, 2011 3:33 am | by Bio-Medicine.Org | News | Comments

NEW YORK, Sept. 8, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: Global Intravascular Ultrasound (IVUS) Industry ...

S. Korea's Medical Charity Program Bolsters Care for Int'l Child Patients

September 8, 2011 2:33 am | by Bio-Medicine.Org | News | Comments

SEOUL, South Korea, Sept. 8, 2011 /PRNewswire-Asia/ -- The Ministry of Health and Welfare (Minister: Chin Soo-hee) and the Korea Health Industry Development Institute (KHIDI, President: Ko Kyung-hwa) plan to invite 25 international child patients, from seven countries, to Korea over the...

Boehringer Ingelheim and Lilly to Feature Type 2 Diabetes Research in Presentations at the 47th Annual Meeting of the European Association for the Study of Diabetes

September 7, 2011 6:33 am | by Bio-Medicine.Org | News | Comments

RIDGEFIELD, Conn. and INDIANAPOLIS, Sept. 7, 2011 /- Boehringer Ingelheim and Eli Lilly and Company (NYSE: LLY ) will present the latest data from their diabetes portfolio at the 47th Annual Meeting of the European Association for the Study of Diabetes (EASD) in Lisbon, Portugal,...

Polar Team2 Pro Set Solution Is Official Heart Rate Training System for the Atlanta Falcons

September 7, 2011 6:33 am | by Bio-Medicine.Org | News | Comments

LAKE SUCCESS, N.Y., Sept. 7, 2011 /- As NFL coaches and players face a dramatically shortened pre-season to ramp-up their strength and conditioning programs, one team's preparation will be gaining a competitive edge as it defends its NFC South title during the 2011 NFL season. Today,...

ThermoGenesis Presentation at Rodman & Renshaw Conference

September 7, 2011 2:33 am | by Bio-Medicine.Org | News | Comments

RANCHO CORDOVA, Calif., Sept. 7, 2011 /- ThermoGenesis Corp. (NASDAQ: KOOL ), a leading supplier of innovative products and services that process and store adult stem cells, announced today that it will be participating in the Rodman & Renshaw 13th Annual Healthcare Conference on...

Cardiosolutions pumps up war chest with new funding

September 6, 2011 12:35 pm | by Mass High Tech: The Journal of New England Technology | News | Comments

Medical device company Cardiosolutions Inc. of West Bridgewater, has raised $3.3 million of what it plans as a $6.5 million funding round, the first funding the company has taken in since late 2009.

HeartSine® Technologies Named One of the Most Innovative Businesses in the United Kingdom

September 6, 2011 12:35 pm | by Bio-Medicine.Org | News | Comments

NEWTOWN, Pa., Sept. 6, 2011 /- HeartSine ® Technologies, Inc., a world leader in personal and public access defibrillators, announced that it is a finalist to receive the coveted Orange Innovation Award in the 10th annual UK National Business Awards. HeartSine was selected because...

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading